US BROKER MOVES: TMO upgraded at UBS; VMC downgraded at Wells Fargo
Newsquawk StaffPublished
Newsquawk headlinesUTC
Every headline is on the live feed 20 minutes before this site.
Gap (GAP) hires Jamie Drew as its new head of strategic partnerships and growth, Business Insider reports
Arabic sources reported intense clashes between mercenaries affiliated with Saudi Arabia and the UAE, reportedly following successive defeats by Houthi forces on various fronts in Yemen, SNN reports
US BROKER MOVES: TMO upgraded at UBS; VMC downgraded at Wells Fargo
FedEx (FDX) files to sell USD-denominated 10-year notes
OpenAI is reportedly projecting compute spending of c. USD 750bln through 2030 but still feels "really short" on computing power, NYT reports
On the Newsquawk feed at , 20 minutes before this page.
Use the PlatformFree. No signup, no card.
UPGRADES
- Figure Technology Solutions (FIGR) Upgraded from Underperform to Neutral at BofA Securities; PT USD 49
- Lithium Americas (LAC) Upgraded from Neutral to Overweight at JPMorgan; PT USD 6
- Lineage (LINE) Upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 47
- Martin Marietta Materials (MLM) Upgraded from Equal Weight to Overweight at Wells Fargo; PT USD 609
- Sagimet Biosciences (SGMT) Upgraded from Equalweight to Overweight at Barclays; PT USD 18
- Summit Therapeutics (SMMT) Upgraded from Hold to Buy at Jefferies; PT USD 25
- Sasol (SSL) Upgraded from Neutral to Buy at BofA Securities
- Thermo Fisher Scientific (TMO) Upgraded from Neutral to Buy at UBS; PT USD 730
- UGI Corp (UGI) Upgraded from Hold to Buy at Jefferies; PT USD 43
DOWNGRADES
- Amrize (AMRZ) Downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 44
- Cheche Group Inc (CCG) Downgraded from Buy to Hold at Maxim Group
- Eagle Materials (EXP) Downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 196
- Patria Investments (PAX) Downgraded from Neutral to Underperform at BofA Securities; PT USD 10
- Vulcan Materials (VMC) Downgraded from Equal Weight to Underweight at Wells Fargo; PT USD 254
- Westlake (WLK) Downgraded from Outperform to Market Perform at BMO Capital; PT USD 82
INITIATIONS
- Agilent Technologies (A) Initiated at Neutral at UBS; PT USD 165
- AEON Biopharma (AEON) Initiated at Buy at Laidlaw; PT USD 1.80
- Akoustis Technologies (AKTS) Initiated at Outperform at Oppenheimer; PT USD 40
- Amneal Pharmaceuticals (AMRX) Initiated at Outperform at Leerink; PT USD 23
- ANI Pharmaceuticals (ANIP) Initiated at Outperform at Leerink; PT USD 104
- Avantor (AVTR) Initiated at Neutral at UBS; PT USD 16
- Better Home & Finance (BETR) Initiated at Buy at B. Riley; PT USD 26
- Bausch + Lomb (BLCO) Initiated at Outperform at Leerink; PT USD 24
- Bruker (BRKR) Initiated at Neutral at UBS; PT USD 65
- Caris Life Sciences (CAI) Initiated at Neutral at UBS; PT USD 28
- Chime Financial (CHYM) Initiated at Buy at Loop Capital; PT USD 45
- Cigna (CI) Initiated at In Line at Evercore ISI; PT USD 290
- Collegium Pharmaceutical (COLL) Initiated at Buy at Truist Securities; PT USD 49
- Collegium Pharmaceutical (COLL) Initiated at Outperform at Leerink; PT USD 45
- DoorDash (DASH) Initiated at Sector Outperform at Scotiabank; PT USD 275
- Dave (DAVE) Initiated at Buy at Loop Capital; PT USD 500
- Danaher (DHR) Initiated at Buy at UBS; PT USD 250
- FuelCell Energy (FCEL) Initiated at Buy at Craig; PT USD 22
- Faeth Therapeutics (FTH) Initiated at Buy at TD Cowen
- Formula One Group (FWONK) Initiated at Buy at Jefferies; PT USD 115
- Guardant Health (GH) Initiated at Buy at UBS; PT USD 225
- Grail (GRAL) Initiated at Buy at UBS; PT USD 105
- Harrow (HROW) Initiated at Outperform at Leerink; PT USD 45
- Heartflow (HTFL) Initiated at Neutral at UBS; PT USD 55
- Illumina (ILMN) Initiated at Buy at UBS; PT USD 260
- Kodiak AI (KDK) Initiated at Buy at Needham; PT USD 8
- Lindblad Expeditions (LIND) Initiated at Hold at Jefferies; PT USD 29
- Lyft (LYFT) Initiated at Sector Perform at Scotiabank; PT USD 17
- MBGL (MBGL) Initiated at In Line at Evercore ISI; PT USD 22
- Monarch Casino & Resort (MCRI) Initiated at Buy at Texas Capital Securities; PT USD 147
- Mettler-Toledo (MTD) Initiated at Neutral at UBS; PT USD 1,460
- Myriad Genetics (MYGN) Initiated at Neutral at UBS; PT USD 3.60
- Nautilus Biotechnology (NAUT) Initiated at Outperform at Leerink; PT USD 4
- Natera (NTRA) Initiated at Buy at UBS; PT USD 435
- Obsidian Therapeutics (OBX) Initiated at Outperform at William Blair
- Pacific Biosciences (PACB) Initiated at Neutral at UBS; PT USD 1.35
- Pacira BioSciences (PCRX) Initiated at Market Perform at Leerink; PT USD 28
- Phathom Pharmaceuticals (PHAT) Initiated at Market Perform at Leerink; PT USD 10
- Pulse Biosciences (PLSE) Initiated at Buy at Freedom Capital; PT USD 73
- Pursuit Attractions and Hospitality (PRSU) Initiated at Buy at Jefferies; PT USD 61
- Pasqal Holding (PSQL) Initiated at Buy at Roth; PT USD 20
- QIAGEN (QGEN) Initiated at Neutral at UBS; PT USD 47
- Repligen (RGEN) Initiated at Buy at UBS; PT USD 225
- Red Rock Resorts (RRR) Initiated at Buy at Texas Capital Securities; PT USD 72
- Revvity (RVTY) Initiated at Neutral at UBS; PT USD 140
- Sagimet Biosciences (SGMT) Initiated at Overweight at Cantor Fitzgerald
- SoFi Technologies (SOFI) Initiated at Hold at Loop Capital; PT USD 22
- Stevanato Group (STVN) Initiated at Neutral at UBS
- Tempus AI (TEM) Initiated at Neutral at UBS; PT USD 70
- Teva Pharmaceutical (TEVA) Initiated at Outperform at Leerink; PT USD 45
- TriSalus Life Sciences (TLSI) Initiated at Buy at H.C. Wainwright; PT USD 11
- Twist Bioscience (TWST) Initiated at Neutral at UBS; PT USD 144
- 10x Genomics (TXG) Initiated at Neutral at UBS; PT USD 68
- Uber (UBER) Initiated at Sector Outperform at Scotiabank; PT USD 100
- Upstart (UPST) Initiated at Hold at Loop Capital; PT USD 34
- Viatris (VTRS) Initiated at Outperform at Leerink; PT USD 20
- Waters (WAT) Initiated at Buy at UBS; PT USD 490
- West Pharmaceutical Services (WST) Initiated at Buy at UBS; PT USD 415
- XPeng (XPEV) Initiated at Neutral at UBS
Related headlines
- US PRE-MARKET MOVERS: Mag7, Memory names, JPM, GS, WFC, JNJ, UNH, DPZ, NVTS, S, FUN, BNTX, SNDX5 hours ago
- US EQUITY OPEN: NDX underperforms as memory name sell-off continues as US earnings season begins3 hours ago
- US BROKER MOVES: VFC sees a couple of upgrades; ADBE downgraded at HSBC5 hours ago
- Newsquawk Daily US Earnings Estimates - 14th October 2026: BLK, BAC, MS, ASML1 hour ago
- Newsquawk European Market Wrap - 13th October 20263 hours ago
- Johnson & Johnson (JNJ) Q3 2026 (USD): Adj. EPS 2.59 (exp. 2.67), Revenue 25.4bln (exp. 25.38bln), sees FY26 Adj. EPS between 11.05-11.15 (prev. 10.96-11.11) and Revenue 101-101.4 (prev. 100.8-101.4bln)6 hours ago
- Wells Fargo (WFC) CFO says given that "we are modestly" asset sensitive, expects Q4 NII, excluding markets, to benefit from higher interest rate environment 2 hours ago
- Wells Fargo (WFC) CEO says US economic growth continues to be strong, while uncertainty persists due to sticky inflation, Middle East conflict, persistent fiscal deficits and volatile energy markets2 hours ago
- Goldman Sachs (GS) CEO says they are operating in a very good environment for capital markets and investment Banking activity at the moment2 hours ago
- Goldman Sachs (GS) CEO says there is no succession transition or timeline at the Co.3 hours ago
- JPMorgan (JPM) CFO says our AI exposure is still modest compared to overall wholesale funding, but will not be immune to a change in sentiment3 hours ago
- JPMorgan (JPM) CFO says AI expenses in 2026 have been lower than earlier estimates3 hours ago
- Domino's Pizza (DPZ) expects FY26 US SSS towards the "low end" of its low-single-digit range and international SSS around flat4 hours ago
- JPMorgan (JPM) CFO on IB pipeline, says there was a slowdown in second half of September and it remains robust4 hours ago
- Citi (C) raises FY26 NII to 'up mid-to-high 6%' (prev. +5-6%)4 hours ago
- Citigroup Inc. (C) Q3 2026 (USD): EPS 2.85 (exp. 2.65), Revenue 23.8bln (exp. 23.72bln)5 hours ago
- Wells Fargo (WFC) CFO says trading activity across clients slowed meaningfully in the last few weeks of September which impacted results5 hours ago
- JPMorgan (JPM) sees Q4 NII at USD 25.5bln and raises FY26 NII to USD 106.2bln (exp. 105.28bln, prev. 105.5bln)5 hours ago
- JPMorgan Chase & Co. (JPM) Q3 2026 (USD): EPS 5.57 (exp. 5.93), Revenue 50.2bln (exp. 51.23bln)6 hours ago
- Wells Fargo (WFC) Q3 2026 (USD): EPS 1.87 (exp. 1.85), Revenue 21.9bln (exp. 22.31bln), NII 12.5bln (exp. 12.7bln)6 hours ago
The feed had this first.
Use the Platform